Please wait a minute...
European Journal of Gynaecological Oncology  2018, Vol. 39 Issue (6): 977-983    DOI: 10.12892/ejgo4539.2018
Original Research Previous articles | Next articles
Lymphovascular space invasion and positive peritoneal cytology are independent prognostic factors for lymph node metastasis and recurrence in endometrial cancer
N. Yildirim1, *(), A. Bilgi1, S.G. Gokulu1, L. Akman1, O. Zekioglu2, G. Serin2, N. Ozdemir2, S. Alanyali3, Z. Ozsaran3, A.A. Ozsaran1, M.C. Terek1
1 Department of Obstetrics & Gynecology, Ege University, İzmir, Turkey
2 Department of Pathology, Ege University, İzmir, Turkey
3 Department of Radiation Oncology, Faculty of Medicine, Ege University, İzmir, Turkey
Download:  PDF(112KB)  ( 68 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Aim: The aim is to identify the risk factors for recurrence and lymphatic metastasis of endometrial cancer. Materials and Methods: Patients who were operated primarily for endometrial cancer between 2010-2016 were included. Parameters such as stage, grade, histology, depth of invasion, cytology status, lymphovascular space invasion (LVSI), and tumor size were recorded. Univariate and multivariate logistic regression models were used to identify pathological predictors of lymphatic dissemination and recurrence. Results: A total of 278 patients were evaluated. Mean age was 60. 80% were Stage I, 10% were Stage III, and 4% were Stage IV, and 36.7% of patients had LVSI. Lymphadenectomy was performed in 56% of patients and lymphatic metastasis was observed in 7.1% of patients. In 13 patients, recurrence occurred; seven were loco-regional and six were distant. Three patients who had recurrence (3/13) were in early stage. With multivariate analysis, LVSI [OR = 8.826;1.874-41.576 (95%CI), p = 0.006] and positive cytology [OR = 9.503;1.811- 49.876 (95%CI), p = 0.008] were independent factors for recurrence in endometrial cancer. Additionally, for lymphatic metastasis, LVSI [OR = 6.195;1.258-30.506 (95%CI), p = 0.025] and positive cytology [OR = 14.258; 2.330-87.247 (95%CI), p = 0.004] were found as significant risk factors. Conclusion: LVSI and positive cytology are significant risk factors for lymphatic metastasis and recurrence in endometrial cancer. Patients who had these risk factors should be followed-up more cautiously in terms of recurrence.
Key words:  Endometrial cancer      Lymph node      Lymphovascular space invasion      Peritoneal cytology      Recurrence     
Published:  10 December 2018     
*Corresponding Author(s):  N. YILDIRIM     E-mail:  nuri-yildirim@hotmail.com

Cite this article: 

N. Yildirim, A. Bilgi, S.G. Gokulu, L. Akman, O. Zekioglu, G. Serin, N. Ozdemir, S. Alanyali, Z. Ozsaran, A.A. Ozsaran, M.C. Terek. Lymphovascular space invasion and positive peritoneal cytology are independent prognostic factors for lymph node metastasis and recurrence in endometrial cancer. European Journal of Gynaecological Oncology, 2018, 39(6): 977-983.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4539.2018     OR     https://ejgo.imrpress.com/EN/Y2018/V39/I6/977

[1] Burak Tatar. Risk of nodal metastasis associated with lymphovascular space invasion in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 850-854.
[2] Jaswinder Chalia, Musse Hussein, Mariya Farooqui, Jordan Mattson, Sally A. Mullany, Molly E. Klein, Boris Winterhoff, Mahmoud A. Khalifa. Concurrent immunohistochemical testing of L1CAM and MMR proteins adds value in risk stratification of endometrial cancer: a proof of concept[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 887-892.
[3] Polo Cornelisz Vermolen, Nienke E. van Trommel, Wouter V. Vogel, Judit A. Adam, Jacobus van der Velden, Constantijne H. Mom. The issue of false positive lymph nodes on [18F] FDG-PET/CT for cervical carcinoma and consequences for treatment[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 943-950.
[4] Felix Chan, Cherynne Yuin Mun Johansson. Single-site robotic-assisted hysterectomy and sentinel lymph node mapping for low-risk endometrial cancer: surgical technique and preliminary outcomes[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 966-972.
[5] Maria Jesús Pla Farnós, Maria Eulalia Fernández-Montolí, Rosalía Pascal Capdevila, Amparo García Tejedor, Míriam Campos Delgado, Maite Bajen Lázaro, Anna Petit Montserrat, Raul Ortega Martínez, Evelyn Martínez Pérez, Sonia Pernas Simón, Jordi Ponce Sebastià. Role of sentinel node biopsy in breast cancer: a review[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 982-995.
[6] Englert-Golon Monika, Słopień Radosław, Smolarek Natalia, Burchardt Bartosz, Sajdak Stefan. Synchronous ovarian, endometrial and cervical cancer—case report[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1093-1094.
[7] Raffaella Fabbri, Rossella Vicenti, Roberto Paradisi, Maria Macciocca, Valentina Magnani1, Lucia DE Meis, Stefania Rossi, Massimo Eraldo Abate, Stefania Benini, Renato Seracchioli. Ovarian tissue cryopreservation after chemotherapy and successful pregnancy after autograft and additional chemotherapy[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1095-1098.
[8] Laura Baquedano Mainar, Javier Navarro Sierra, Leticia Alvarez Sarrado, Yasmina José Gutiérrez, Marta Lamarca Ballestero, Patricia Rubio Cuesta, Ana C. Ruiz Peña, Andrea Espiau Romera. Clinical and demographic factors in endometrial and ovary carcinoma: synchronous carcinoma vs stage IIIA endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 643-648.
[9] Reem D. Mahmood, Robert D. Morgan, Tine Descamps, Claire Mitchell, Jurjees Hasan, Nerissa Mescallado, Lisa Barraclough, Kate Haslett, Jacqueline Livsey, Emma J. Crosbie, Richard J. Edmondson, Gordon C. Jayson, Andrew R. Clamp. Sequential chemotherapy-radiotherapy as adjuvant treatment of high-risk endometrial carcinoma: a retrospective review of the Manchester experience[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 673-681.
[10] Woraphot Chaowawanit, Vicki Campbell, Emily Wilson, Naven Chetty, Lewis Perrin, Nisha Jagasia, Sinead Barry. Retrospective review of sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging during minimally invasive surgery[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 694-702.
[11] Hao Lin, Hung-Chun Fu, Fu-Tsai Kung, Yu-Jen Chen, Chan-Chao Chang Chien, Chen-Hsuan Wu, Ching-Chou Tsai, Yu-Che Ou. A comparison of laparoscopic and open surgery for early stage endometrial cancer with analysis of prognostic factors: a propensity score matching study[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 703-710.
[12] Maria Szymankiewicz, Sebastian Szubert. Microbiological characteristics of early and late infectious complications following total pelvic exenteration due to cervical cancer recurrence—the significance of infections in long-term outcomes[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 742-751.
[13] Tomoko Sakamoto Taniguchi, Shinichi Komiyama, Masaru Nagashima, Mineto Morita. Characteristics of microsatellite instability-high gynecologic cancer and efficacy of pembrolizumab: a single-institution experience[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 752-756.
[14] Erdem Cubukcu, Ahmet Bilgehan Sahin, Fatma Oz Atalay, Birol Ocak, Mine Ozsen, Candan Demiroz Abakay, Kemal Ozerkan, Ulviyya Hasanzade, Merve Mesohorli, Adem Deligonul, Hakan Ozan, Turkkan Evrensel. The Ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 775-781.
[15] Nikolaos Giannakopoulos, Ivana Virijevic, Merit Kullinger. Isolated vulvar metastasis after robot-assisted laparoscopic hysterectomy for low grade, early stage endometrial cancer: a case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 418-424.
No Suggested Reading articles found!